Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type 2 diabetes: treat to target.

Martha M Funnell1, Davida F Kruger

  • 1Michigan Diabetes Research and Training Center, Ann Arbor, Mich, USA.

The Nurse Practitioner
|January 17, 2004
PubMed
Summary

Early insulin therapy for type 2 diabetes offers benefits beyond glycemic control. Introducing insulin sooner can help prevent long-term complications and mimic natural insulin function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinician Guidance on the Benefits of Healthy Nutrition and Increased Physical Activity for People With Type 2 Diabetes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation.

Clinical diabetes : a publication of the American Diabetes Association·2025
Same author

The role of advanced technologies in improving diabetes outcomes.

The American journal of managed care·2025
Same author

Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies.

Journal of diabetes science and technology·2025
Same author

Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.

JAMA network open·2025
Same author

A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin.

Diabetes technology & therapeutics·2025
Same author

The Michigan Men's Diabetes Project Randomized Clinical Control Trial: A Pilot/Feasibility Study of a Peer-Led Diabetes Self-Management and Support Intervention for Black Men With Type 2 Diabetes.

American journal of men's health·2024

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Type 2 diabetes management traditionally delays insulin initiation.
  • Oral agents and lifestyle changes are often insufficient for long-term glycemic control.
  • Physiologic insulin secretion is key to metabolic homeostasis.

Purpose of the Study:

  • To evaluate the benefits of earlier insulin therapy in type 2 diabetes.
  • To explore insulin's role in preventing diabetes-associated comorbidities.
  • To assess insulin's efficacy in normalizing glycemic control.

Main Methods:

  • Review of current clinical evidence and guidelines.
  • Analysis of studies comparing early versus delayed insulin initiation.
  • Examination of data on disease progression and complication rates.

Main Results:

  • Evidence supports earlier insulin use for improved glycemic control.
  • Early insulin therapy can help delay or prevent diabetes complications.
  • Insulin initiation can better emulate normal insulin secretion patterns.

Conclusions:

  • Advancing insulin therapy earlier in type 2 diabetes is recommended.
  • Early insulin use improves metabolic control and reduces comorbidity risk.
  • Insulin therapy is a critical tool for long-term diabetes management.

Related Experiment Videos